Scientists probe how eczema drug rewires skin to stop the itch
NCT ID NCT04823130
Summary
This study aimed to understand how the approved eczema medication dupilumab works to reduce chronic itching. Researchers took small skin samples from 54 adults with moderate-to-severe eczema before and after treatment to see if the drug changed nerve fibers in the skin. The goal was to learn the biological reasons behind the drug's ability to relieve itch, not to test if the drug was safe or effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 2760001
Münster, 48149, Germany
-
Investigational Site Number 8400001
Miami, Florida, 33136, United States
-
Investigational Site Number 8400002
East Windsor, New Jersey, 08520, United States
Conditions
Explore the condition pages connected to this study.